Clin 0001 amplicon metagenomics sequenci
Ended Purchase Order Awarded Last action
- Contract number
- N3239824P0701
- Awardee
-
Novogene Corporation Inc. UEI KM6KF2YEWNN6
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $49,800
Award facts
- Contract value 100% obligated
- $49,800.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$16,600 | |
| Other Administrative Action | $0 | |
| Original award | $66,400 |
About this award
Novogene Corporation Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services, has been awarded a $49.8K purchase order by the Bureau of Medicine and Surgery, a Defense agency component, for amplicon metagenomics sequencing services. This firm fixed-price contract, issued February 22, 2024, represents a reduction in unit quantities from a prior award and includes a mandatory Non-Disclosure Agreement to be executed by all contract personnel and their management. Work will be performed at Fort Sam Houston in San Antonio, Texas, with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation.
Amplicon metagenomics sequencing enables the identification and analysis of microbial communities through targeted amplification and sequencing of specific genomic regions, supporting the Department of Defense's biomedical research objectives. This award reflects Novogene's established capabilities in next-generation sequencing technologies and reflects the company's track record delivering genomic research services across multiple federal agencies including the National Institutes of Health, U.S. Department of Agriculture, and U.S. Geological Survey. The contract follows Novogene's existing significant Blanket Purchase Agreement with the U.S. Geological Survey valued at $120K, demonstrating the contractor's ability to maintain sustained service relationships with federal research institutions.
Quick answers
Who was awarded contract N3239824P0701?
N3239824P0701 was awarded to Novogene Corporation Inc. by Bureau of Medicine and Surgery (Department of the Navy) on February 22, 2024.
How much is contract N3239824P0701 worth?
The government has obligated $49,800 on N3239824P0701.
Was contract N3239824P0701 competed?
The extent of competition for N3239824P0701 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award